APA (7th ed.) Citation

Havens, J. P., Bares, S. H., Lyden, E., Podany, A. T., Scarsi, K. K., Fadul, N., & Swindells, S. (2023). Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Patients With HIV-1 Infection and Ongoing Substance Use Disorder: The BASE Study. Open Forum Infectious Diseases, 10(3), 1. https://doi.org/10.1093/ofid/ofad080

Chicago Style (17th ed.) Citation

Havens, Joshua P., Sara H. Bares, Elizabeth Lyden, Anthony T. Podany, Kimberly K. Scarsi, Nada Fadul, and Susan Swindells. "Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Patients With HIV-1 Infection and Ongoing Substance Use Disorder: The BASE Study." Open Forum Infectious Diseases 10, no. 3 (2023): 1. https://doi.org/10.1093/ofid/ofad080.

MLA (9th ed.) Citation

Havens, Joshua P., et al. "Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Patients With HIV-1 Infection and Ongoing Substance Use Disorder: The BASE Study." Open Forum Infectious Diseases, vol. 10, no. 3, 2023, p. 1, https://doi.org/10.1093/ofid/ofad080.